Overview

Location [1]
3p25.2
Protein [2]
Peroxisome proliferator-activated receptor gamma
Synonyms [1]
PPARgamma, GLM1, PPARG2, NR1C3, CIMT1, PPARG1

Peroxisome proliferator-activated receptor gamma (PPARG) is a gene that encodes a protein that functions as a nuclear receptor. The protein also regulates adipocyte differentiation. Fusions, missense mutations, nonsense mutations, silent mutations, and frameshift deletions are observed in cancers such as endometrial cancer, skin cancer, and stomach cancer.

PPARG is altered in 1.01% of all cancers with bladder urothelial carcinoma, cutaneous melanoma, lung adenocarcinoma, melanoma, and endometrial endometrioid adenocarcinoma having the greatest prevalence of alterations [3].

PPARG GENIE Cases - Top Diseases

The most common alterations in PPARG are PPARG Amplification (0.22%), PPARG S186fs (0.03%), PPARG T475M (0.04%), PPARG Loss (0.03%), and PPARG E79K (0.02%) [3].

PPARG GENIE Cases - Top Alterations

Significance of PPARG in Diseases

Thyroid Gland Carcinoma +

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.